Performance of INCY Incyte | -4.9% in 12m
Compare INCY with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Incyte with its related Sector/Index XBI
Performance Duell INCY vs XBI
| TimeFrame | INCY | XBI |
|---|---|---|
| 1 Week | -6.70% | -4.68% |
| 1 Month | -0.02% | 2.20% |
| 3 Months | 4.88% | 4.12% |
| 6 Months | 3.37% | -3.48% |
| 12 Months | -4.89% | 22.61% |
| YTD | -6.40% | 7.10% |
| Rel. Perf. 1m | -0.19 | |
| Rel. Perf. 3m | 0.39 | |
| Rel. Perf. 6m | 0.47 | |
| Rel. Perf. 12m | 0.47 | |
| Spearman 1m | 0.62 | 0.47 |
| Spearman 3m | 0.43 | 0.70 |
Is Incyte a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Incyte is currently (September 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INCY as of September 2024 is 56.26. This means that INCY is currently overvalued and has a potential downside of -8.16% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INCY as of September 2024 is 56.26. This means that INCY is currently overvalued and has a potential downside of -8.16% (Sold with Premium).
Is INCY a buy, sell or hold?
- Strong Buy: 10
- Buy: 2
- Hold: 12
- Sell: 1
- Strong Sell: 0
Values above 0%: INCY is performing better - Values below 0%: INCY is underperforming
Compare INCY with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.56% | -3.51% | -3.31% | -27.07% |
| US NASDAQ 100 | QQQ | -0.91% | -2.10% | 0.82% | -24.74% |
| US Dow Jones Industrial 30 | DIA | -3.88% | -3.82% | -1.93% | -23.39% |
| German DAX 40 | DBXD | -3.46% | -5.42% | 0.54% | -19.49% |
| UK FTSE 100 | ISFU | -4.45% | -6.29% | -8.95% | -23.05% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.02% | 2.29% | 9.64% | 6.02% |
| Hongkong Hang Seng | HSI | -4.48% | -4.79% | 2.86% | 0.95% |
| Japan Nikkei 225 | EXX7 | 0.42% | -5.70% | 13.50% | -10.75% |
| India NIFTY 50 | INDA | -4.60% | -2.63% | -5.07% | -29.20% |
| Brasil Bovespa | EWZ | -4.99% | -6.90% | 11.88% | -5.13% |
INCY Incyte vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.63% | -0.61% | -4.00% | -29.41% |
| Consumer Discretionary | XLY | -4.18% | -5.41% | 1.38% | -10.98% |
| Consumer Staples | XLP | -7.28% | -6.09% | -8.45% | -23.04% |
| Energy | XLE | -0.93% | 1.10% | 3.05% | -2.75% |
| Financial | XLF | -3.53% | -6.74% | -6.53% | -35.63% |
| Health Care | XLV | -4.63% | -4.39% | -2.86% | -22.54% |
| Industrial | XLI | -2.46% | -3.17% | -0.84% | -25.96% |
| Materials | XLB | -2.04% | -1.61% | 1.27% | -16.54% |
| Real Estate | XLRE | -6.88% | -5.03% | -8.40% | -28.26% |
| Technology | XLK | 0.75% | -1.68% | 4.62% | -23.21% |
| Utilities | XLU | -6.20% | -4.19% | -18.75% | -28.65% |
| Aerospace & Defense | XAR | -1.49% | -4.02% | -1.10% | -31.23% |
| Biotech | XBI | -2.02% | -2.22% | 6.85% | -27.50% |
| Homebuilder | XHB | -2.30% | -3.44% | -4.47% | -42.49% |
| Retail | XRT | -1.72% | 0.49% | 6.62% | -23.54% |
Does Incyte outperform its market, is INCY a Sector Leader?
No, over the last 12 months Incyte (INCY) made -4.89%, while its related Sector, the SPDR S&P Biotech (XBI) made 22.61%.
Over the last 3 months INCY made 4.88%, while XBI made 4.12%.
No, over the last 12 months Incyte (INCY) made -4.89%, while its related Sector, the SPDR S&P Biotech (XBI) made 22.61%.
Over the last 3 months INCY made 4.88%, while XBI made 4.12%.
| Period | INCY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.02% | 2.20% | 3.49% |
| 3 Months | 4.88% | 4.12% | 1.39% |
| 12 Months | -4.89% | 22.61% | 22.18% |